Icade Santé SAS reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 325.1 million compared to EUR 297.9 million a year ago. Revenue was EUR 355.2 million compared to EUR 325.7 million a year ago.

Net income was EUR 378.4 million compared to EUR 490.7 million a year ago. Basic earnings per share from continuing operations was EUR 9.59 compared to EUR 12.92 a year ago. Diluted earnings per share from continuing operations was EUR 9.59 compared to EUR 12.92 a year ago.